JAZZ logo

Jazz Pharmaceuticals (JAZZ) Net income

annual net income:

$560.12M+$145.29M(+35.02%)
December 31, 2024

Summary

  • As of today (May 20, 2025), JAZZ annual net profit is $560.12 million, with the most recent change of +$145.29 million (+35.02%) on December 31, 2024.
  • During the last 3 years, JAZZ annual net income has risen by +$889.79 million (+269.90%).
  • JAZZ annual net income is now at all-time high.

Performance

JAZZ Net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJAZZincome statement metrics

quarterly net income:

-$92.54M-$283.66M(-148.42%)
March 1, 2025

Summary

  • As of today (May 20, 2025), JAZZ quarterly net profit is -$92.54 million, with the most recent change of -$283.66 million (-148.42%) on March 1, 2025.
  • Over the past year, JAZZ quarterly net income has dropped by -$77.92 million (-533.06%).
  • JAZZ quarterly net income is now -135.33% below its all-time high of $261.90 million, reached on June 30, 2019.

Performance

JAZZ quarterly net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJAZZincome statement metrics

TTM net income:

$482.20M-$77.92M(-13.91%)
March 1, 2025

Summary

  • As of today (May 20, 2025), JAZZ TTM net profit is $482.20 million, with the most recent change of -$77.92 million (-13.91%) on March 1, 2025.
  • Over the past year, JAZZ TTM net income has increased by +$151.40 million (+45.77%).
  • JAZZ TTM net income is now -26.48% below its all-time high of $655.88 million, reached on June 30, 2019.

Performance

JAZZ TTM net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJAZZincome statement metrics

Net income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

JAZZ Net income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+35.0%-533.1%+45.8%
3 y3 years+269.9%-5718.8%+207.2%
5 y5 years+7.0%+41.4%+72.0%

JAZZ Net income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+269.9%-143.0%+61.6%-13.9%+207.2%
5 y5-yearat high+269.9%-143.0%+74.5%-13.9%+207.2%
alltimeall timeat high+269.9%-135.3%+74.5%-26.5%+207.2%

JAZZ Net income History

DateAnnualQuarterlyTTM
Mar 2025
-
-$92.54M(-148.4%)
$482.20M(-13.9%)
Dec 2024
$560.12M(+35.0%)
$191.12M(-11.1%)
$560.12M(+20.9%)
Sep 2024
-
$215.06M(+27.6%)
$463.16M(+17.3%)
Jun 2024
-
$168.57M(-1253.2%)
$394.92M(+19.4%)
Mar 2024
-
-$14.62M(-115.5%)
$330.79M(-20.3%)
Dec 2023
$414.83M(-285.1%)
$94.15M(-35.9%)
$414.83M(+418.8%)
Sep 2023
-
$146.82M(+40.6%)
$79.95M(-192.4%)
Jun 2023
-
$104.44M(+50.4%)
-$86.51M(-44.6%)
Mar 2023
-
$69.42M(-128.8%)
-$156.29M(-30.2%)
Dec 2022
-$224.06M(-32.0%)
-$240.72M(+1125.2%)
-$224.06M(+1099.0%)
Sep 2022
-
-$19.65M(-156.7%)
-$18.69M(-64.0%)
Jun 2022
-
$34.66M(+2004.7%)
-$51.87M(-88.5%)
Mar 2022
-
$1.65M(-104.7%)
-$449.85M(+36.5%)
Dec 2021
-$329.67M(-238.2%)
-$35.35M(-33.1%)
-$329.67M(+104.9%)
Sep 2021
-
-$52.83M(-85.5%)
-$160.90M(-500.6%)
Jun 2021
-
-$363.32M(-398.2%)
$40.16M(-92.3%)
Mar 2021
-
$121.83M(-8.7%)
$518.28M(+117.2%)
Dec 2020
$238.62M(-54.4%)
$133.41M(-10.0%)
$238.62M(+33.2%)
Sep 2020
-
$148.23M(+29.1%)
$179.19M(+34.5%)
Jun 2020
-
$114.80M(-172.7%)
$133.24M(-52.5%)
Mar 2020
-
-$157.83M(-313.3%)
$280.33M(-46.4%)
Dec 2019
$523.37M(+17.1%)
$73.99M(-27.7%)
$523.37M(-14.0%)
Sep 2019
-
$102.28M(-60.9%)
$608.85M(-7.2%)
Jun 2019
-
$261.90M(+207.4%)
$655.88M(+34.9%)
Mar 2019
-
$85.20M(-46.6%)
$486.31M(+8.8%)
Dec 2018
$447.10M(-8.4%)
$159.47M(+6.8%)
$447.10M(-14.0%)
Sep 2018
-
$149.32M(+61.7%)
$519.84M(+19.8%)
Jun 2018
-
$92.32M(+100.7%)
$434.05M(-3.0%)
Mar 2018
-
$45.99M(-80.2%)
$447.33M(-8.3%)
Dec 2017
$487.85M(+22.9%)
$232.21M(+265.5%)
$487.85M(+31.0%)
Sep 2017
-
$63.53M(-39.8%)
$372.33M(-6.6%)
Jun 2017
-
$105.60M(+22.1%)
$398.63M(-2.2%)
Mar 2017
-
$86.51M(-25.9%)
$407.53M(+2.7%)
Dec 2016
$396.83M(+20.4%)
$116.69M(+29.9%)
$396.83M(+9.3%)
Sep 2016
-
$89.83M(-21.5%)
$362.90M(+0.5%)
Jun 2016
-
$114.50M(+51.0%)
$361.04M(+7.9%)
Mar 2016
-
$75.81M(-8.4%)
$334.65M(+1.6%)
Dec 2015
$329.54M(+464.4%)
$82.76M(-5.9%)
$329.54M(+0.3%)
Sep 2015
-
$87.96M(-0.2%)
$328.39M(+23.4%)
Jun 2015
-
$88.11M(+24.6%)
$266.19M(+20.0%)
Mar 2015
-
$70.70M(-13.4%)
$221.74M(+279.8%)
DateAnnualQuarterlyTTM
Dec 2014
$58.39M(-73.0%)
$81.61M(+216.7%)
$58.39M(+82.1%)
Sep 2014
-
$25.77M(-41.0%)
$32.07M(-60.8%)
Jun 2014
-
$43.66M(-147.1%)
$81.71M(+1.8%)
Mar 2014
-
-$92.65M(-267.6%)
$80.24M(-62.9%)
Dec 2013
$216.31M(-25.0%)
$55.29M(-26.7%)
$216.31M(-40.2%)
Sep 2013
-
$75.41M(+78.8%)
$361.57M(+13.2%)
Jun 2013
-
$42.19M(-2.9%)
$319.37M(+4.9%)
Mar 2013
-
$43.42M(-78.3%)
$304.33M(+5.5%)
Dec 2012
$288.59M(+130.9%)
$200.55M(+503.9%)
$288.59M(+129.9%)
Sep 2012
-
$33.21M(+22.3%)
$125.51M(+0.6%)
Jun 2012
-
$27.14M(-1.9%)
$124.78M(-4.6%)
Mar 2012
-
$27.68M(-26.1%)
$130.84M(+4.7%)
Dec 2011
$124.98M(+281.3%)
$37.47M(+15.4%)
$124.98M(+11.6%)
Sep 2011
-
$32.48M(-2.2%)
$111.97M(+20.7%)
Jun 2011
-
$33.20M(+52.1%)
$92.73M(+74.5%)
Mar 2011
-
$21.83M(-10.8%)
$53.14M(+62.1%)
Dec 2010
$32.78M(-579.5%)
$24.46M(+84.7%)
$32.78M(+134.6%)
Sep 2010
-
$13.24M(-307.3%)
$13.97M(-1581.7%)
Jun 2010
-
-$6.39M(-536.3%)
-$943.00K(-112.4%)
Mar 2010
-
$1.46M(-74.1%)
$7.62M(-211.4%)
Dec 2009
-$6.84M(-96.3%)
$5.65M(-438.1%)
-$6.84M(-90.2%)
Sep 2009
-
-$1.67M(-177.0%)
-$69.43M(-28.1%)
Jun 2009
-
$2.17M(-116.7%)
-$96.57M(-35.9%)
Mar 2009
-
-$12.99M(-77.2%)
-$150.62M(-18.3%)
Dec 2008
-$184.34M(+32.8%)
-$56.94M(+97.6%)
-$184.34M(-1.6%)
Sep 2008
-
-$28.81M(-44.5%)
-$187.42M(+5.3%)
Jun 2008
-
-$51.88M(+11.1%)
-$177.97M(+7.2%)
Mar 2008
-
-$46.71M(-22.2%)
-$165.95M(+19.5%)
Dec 2007
-$138.83M(+133.7%)
-$60.02M(+210.0%)
-$138.83M(+52.3%)
Sep 2007
-
-$19.36M(-51.4%)
-$91.14M(+8.3%)
Jun 2007
-
-$39.86M(+103.5%)
-$84.12M(+48.6%)
Mar 2007
-
-$19.58M(+58.7%)
-$56.59M(-4.7%)
Dec 2006
-$59.39M(-30.3%)
-$12.34M(0.0%)
-$59.39M(-13.1%)
Sep 2006
-
-$12.34M(0.0%)
-$68.34M(-11.6%)
Jun 2006
-
-$12.34M(-44.9%)
-$77.29M(-10.4%)
Mar 2006
-
-$22.38M(+5.1%)
-$86.25M(+1.3%)
Dec 2005
-$85.16M(+243.3%)
-$21.29M(0.0%)
-$85.16M(+33.3%)
Sep 2005
-
-$21.29M(0.0%)
-$63.87M(+50.0%)
Jun 2005
-
-$21.29M(0.0%)
-$42.58M(+100.0%)
Mar 2005
-
-$21.29M
-$21.29M
Dec 2004
-$24.80M
-
-

FAQ

  • What is Jazz Pharmaceuticals annual net profit?
  • What is the all time high annual net income for Jazz Pharmaceuticals?
  • What is Jazz Pharmaceuticals annual net income year-on-year change?
  • What is Jazz Pharmaceuticals quarterly net profit?
  • What is the all time high quarterly net income for Jazz Pharmaceuticals?
  • What is Jazz Pharmaceuticals quarterly net income year-on-year change?
  • What is Jazz Pharmaceuticals TTM net profit?
  • What is the all time high TTM net income for Jazz Pharmaceuticals?
  • What is Jazz Pharmaceuticals TTM net income year-on-year change?

What is Jazz Pharmaceuticals annual net profit?

The current annual net income of JAZZ is $560.12M

What is the all time high annual net income for Jazz Pharmaceuticals?

Jazz Pharmaceuticals all-time high annual net profit is $560.12M

What is Jazz Pharmaceuticals annual net income year-on-year change?

Over the past year, JAZZ annual net profit has changed by +$145.29M (+35.02%)

What is Jazz Pharmaceuticals quarterly net profit?

The current quarterly net income of JAZZ is -$92.54M

What is the all time high quarterly net income for Jazz Pharmaceuticals?

Jazz Pharmaceuticals all-time high quarterly net profit is $261.90M

What is Jazz Pharmaceuticals quarterly net income year-on-year change?

Over the past year, JAZZ quarterly net profit has changed by -$77.92M (-533.06%)

What is Jazz Pharmaceuticals TTM net profit?

The current TTM net income of JAZZ is $482.20M

What is the all time high TTM net income for Jazz Pharmaceuticals?

Jazz Pharmaceuticals all-time high TTM net profit is $655.88M

What is Jazz Pharmaceuticals TTM net income year-on-year change?

Over the past year, JAZZ TTM net profit has changed by +$151.40M (+45.77%)
On this page